TY  - CONF

T1  - 1325 SCOPE, an open label phase 2 parallel multi cohort clinical trial evaluating an off-the-shelf DNA plasmid vaccine in first line advanced melanoma combined with checkpoint blockade – interim read-out

JO  - Late-Breaking Abstracts

UR  - https://doi.org/10.1136/jitc-2025-sitc2025.1325

PY  - 2025/11/04

AU  - Varawalla N

AU  - Shaw H

AU  - Corrie P

AU  - Danson S

AU  - Payne M

AU  - Young K

AU  - Patel P

AU  - Marples M

AU  - Karydis I

AU  - Kumar S

AU  - Barlow C et al

ED  - 

DO  - DOI: 10.1136/jitc-2025-sitc2025.1325

PB  - BMJ Publishing Group Ltd

SP  - A1564

EP  - A1565

Y2  - 2025/12/05

ER  -